In August, Mexico City hosted the tenth edition of the Regenerative Medicine Symposium Regenera by Isiena, an event that brought together researchers, doctors and professionals from the pharmaceutical and biotechnology industries to share experiences and knowledge on advanced therapies.
The programme included interesting presentations on sustainable regenerative therapies, 3D culture, pluripotent stem cells and musculoskeletal applications in regenerative rehabilitation, among other topics.In this context, Dr. Gil Rodas, Medical Director of the Barça Innovation Hub, presented the European project TriAnkle as a cell therapy that manufactures personalised implants based on collagen and gelatin with 3D bioprinting technology to improve the quality of life of patients with tendon and cartilage injuries. This therapy reduces patient recovery times by up to 50%, which in turn generates a very positive impact on the healthcare systems of economies around the world.
